{
  "@context": "aku-v2",
  "@type": "definition",
  "@id": "health-sciences:medicine:cardiology:cardio-004",
  "metadata": {
    "version": "1.0.0",
    "created": "2026-01-09T01:50:10.000Z",
    "contributors": [
      "copilot-agent"
    ],
    "confidence": 0.9,
    "status": "enhanced",
    "modified": "2026-01-09T11:29:00.000Z"
  },
  "classification": {
    "domain_path": "health-sciences/medicine/cardiology",
    "type": "definition",
    "difficulty": "intermediate",
    "importance": "high"
  },
  "content": {
    "title": "Heart Failure Classification",
    "summary": "NYHA functional classification",
    "key_points": [
      "Class I: no limitation",
      "Class II: slight limitation",
      "Class III: marked limitation",
      "Class IV: symptoms at rest"
    ],
    "statement": "Heart failure is classified by left ventricular ejection fraction (LVEF): HFrEF (LVEF \u226440%), HFmrEF (LVEF 41-49%), and HFpEF (LVEF \u226550%), with distinct pathophysiology and treatment approaches.",
    "explanation": {
      "intuition": "Heart failure is a clinical syndrome where the heart cannot pump blood effectively. EF-based classification guides treatment.",
      "key_insight": "GDMT for HFrEF includes the 'four pillars': ARNI/ACEi/ARB, beta-blocker, MRA, and SGLT2i - all reduce mortality.",
      "technical_details": "Stage A-D classification: A=at risk, B=structural disease without symptoms, C=symptomatic HF, D=advanced HF requiring specialized interventions."
    }
  },
  "prerequisites": [],
  "related_concepts": [],
  "evidence": {
    "citations": [],
    "confidence_rationale": "Standard medical/scientific knowledge"
  },
  "learning_objectives": [
    "Understand Heart Failure Classification"
  ],
  "clinical_pearls": [
    "Class I: no limitation"
  ],
  "provenance": {
    "citations": [
      {
        "source": "Heidenreich PA, et al. 2022 AHA/ACC/HFSA Guideline for HF Management. Circulation 2022;145:e895-e1032.",
        "type": "guideline"
      },
      {
        "source": "McDonagh TA, et al. 2021 ESC Guidelines for HF. Eur Heart J 2021;42:3599-3726.",
        "type": "guideline"
      }
    ],
    "verification_status": "pending",
    "last_verified": null
  }
}